Clover biology Shanghai R & D center started work to help develop recombinant protein covid-19 vaccine

Shanghai Shanghai Zhangjiang Hi-Tech Park Development Co.Ltd(600895) Technology Park adds another R & D center. Recently, clover biopharmaceutical Co., Ltd., a global biopharmaceutical company, announced the official commencement of the Shanghai R & D center. In the future, the center will support new vaccines, innovative therapies, preclinical development, production process development and intermediate trial production based on trimer tagtm (protein trimerization) and other technical platforms.